Rheumatoid Arthritis

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) does not prevent pneumonia in rheumatoid arthritis patients, a new study finds.

Advanced techniques allowed researchers to isolate T-cells involved in RA.

Biologics dose individualization should be used more often in clinical practice due to its direct benefit for patients with rheumatoid arthritis, researchers recommend.

Approximately one percent of the general population carries the auto-antibodies associated with rheumatoid arthritis, a new study shows.

A higher initial dose of methotrexate is not always associated with better clinical outcomes for newly diagnosed rheumatoid arthritis patients, a study shows.

Anti-inflammatory treatment in rheumatoid arthritis patients, especially with infliximab added to methotrexate, improves HDL function and may potentially reduce cardiovascular risk, a study shows.

RA patients with low disease activity in the first trimester of pregnancy, are likely to have low disease activity or reach remission by the third trimester.

The association between periodontal disease and rheumatoid arthritis has been well established in studies, but now researchers describe a mechanism that could explain this association.

Analysis finds that those with RA have same mortality rate as those without.

Myocardial inflammation/fibrosis has been identified in a study of rheumatoid arthritis patients with no known history of heart disease.

Some biologics produce hypersensitivity reactions more than others, but for most, the events are low, researchers report.

Methotrexate is "dramatically" underutilized, prescribed at suboptimal levels, prescribed for too short of periods and is not administered correctly, researchers report.

A rheumatoid arthritis patient seeks treatment for ankyloses, or fusion of the finger joints. The patient was successfully treated with silicone arthroplasty.

Women who have rheumatoid arthritis might benefit from treatment with denosumab over alendronate. According to a new study, denosumab is more effective at bone healing.

Asked to assume equal cost-effectiveness, the patients were given eight facets of treatment and asked to rank them between 1 and 8, with 1 being the most important to them and 8 being the least.

Researchers who evaluated adverse events in a large sample of patients taking NSAIDs for arthritis came to a surprising conclusion: celecoxib is the safest of three drugs studied.

Certain types of inflammation go hand-in-hand. Columbia University researchers hypothesized that treatment that lowered arthritis disease activity would also decrease the risk of heart failure.

Biologics might have revolutionized treatment for rheumatoid arthritis, but they can increase the risk of serious infections or hospitalizations in some patients.

When methotrexate fails in rheumatoid arthritis, the next-line treatment is usually a TNF-α inhibitor. But if this treatment fails as well, what's next?

Assessing the elevated risk of aortic aneurysm in rheumatoid arthritis.

Cushingoid appearance is a side effect of glucocorticoid use, but to date, there has been little knowledge about how glucocorticoids can change fat mass and redistribution.

The blistering pace of mobile innovation has opened countless doors for clinical application. Built on Apple's ResearchKit platform, GSK's PARADE app seeks to study rheumatoid arthritis patients in their daily lives.

With the hope of wasting less time on medications doomed to fail, researchers are seeking biomarkers to predict a patient’s response to particular RA treatments.

In this article, we ask the experts to share their thoughts on the roots of doctor-patient communication challenges. Overwhelmed patients, busy doctors and technological communication rose to the top.

Biologics only slightly reduce fatigue in rheumatoid arthritis (RA) patients, a systematic review suggests.